Active Ingredient(s): Asparaginase Erwinia Chrysanthemi (recombinant)-rywn
FDA Approved: * June 30, 2021
Pharm Company: * JAZZ PHARMS
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Rylaze Overview

Asparaginase is an enzyme that is used as a medication and in food manufacturing.[3][4] As a medication, L-asparaginase is used to treat acute lymphoblastic leukemia (ALL).[3] It is given by injection into a vein, muscle, or under the skin.[3] A pegylated version is also available.[5] In food manufacturing it is used to decrease acrylamide.[4] Common side effects when used by injection include alle...

Read more Rylaze Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Asparaginase

Recent Rylaze Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Asparaginase Erwinia Chrysanthemi (recombinant)-rywn
  • Injection: 10,000iu, 10mg/0.5ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Rylaze: (1 result)

Sorted by National Drug Code
  • 68727-900 Rylaze 20 mg/ml Intramuscular Injection by Jazz Pharmaceuticals, Inc.

Other drugs which contain Asparaginase Erwinia Chrysanthemi (recombinant)-rywn or a similar ingredient: (2 results)